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The objective is to asses whether IL-6 upregulation in the skeletal muscle could be used to
treat obesity
Objective
The metodology followed consisted in the extraction of information from both review and 
research scientific papers obtained from the Google Scholar and PubMed databases.
Metodology
Obesity and its associated medical conditions are a worldwide medical problem taking up to 3% of a countries medical care budget.
IL-6 has been reported to act as an exercise factor, and ever since the discovery of this novel function, there has been research focused on
clarifying  the signals that regulate its expression in the skeletal muscle, being the involvement of calcium signaling a consistent result. 
Introduction
1. Contraction-induced ATP release into the extracellular
medium through Pannexin
2. ATP-dependent P2Y-induced IP3 signalling
3. Activation of calcium downstream transcription factors
4. Calcium-mediated IL-6 gene transcription.
5. IL-6 release and IL-6 receptor activation.
6. JAK2/STAT3 pathway activation
7. IL-6-dependent IL-6 gene transcription
8. SOCS3 gene transcription
9. JAK2 inhibition by SOCS3
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Contraction-derived IL-6 acts as an exercise factor increasing FFA uptake
in the skeletal muscle and presumably increasing whole body glucose
metabolism, this occurs in response to an energy demand on the
contracting muscle
Conclusions
1. The ATP and Ca2+ pathway is too inespecific to be
modified to artificially upregulate IL-6
2. The IL-6-dependent pathway is more specific and simple, 
therefore, it could be a good candidate to artificially
upregulate IL-6.
3. The mechanism I propose consists in low-dose IL-6 
administrations into the skeletal muscle to activate the IL-
6 autocine loop
4. Would it have the desired effect?
• RhIL-6 infusions have demonstrated an
increased FFA blood levels
• Without the energy demand FFA do not get
metabolized and create ectopic fat deposits in 
the skeletal muscle
• Increased intramuscular fat deposits have been
positively correlated to insulin resistivity
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